Literature DB >> 16702495

Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography.

Eunice Y Tsai1, Alan Taur, Leandro Espinosa, Andrew Quon, Denise Johnson, Sarah Dick, Steve Chow, Ranjana Advani, Roger Warnke, Sabine Kohler, Richard T Hoppe, Youn H Kim.   

Abstract

OBJECTIVES: To evaluate the usefulness of integrated positron emission tomography and computed tomography (PET/CT) in staging mycosis fungoides (MF) and Sézary syndrome and to correlate PET/CT data with histopathologic diagnosis of lymph nodes (LNs).
DESIGN: A single-center, prospective cohort analysis.
SETTING: Academic referral center for cutaneous lymphoma. PATIENTS: Thirteen patients with MF and SS at risk for secondary LN involvement. Interventions Patients were clinically evaluated based on general physical examination, total body skin examination, and laboratory screening. They underwent integrated PET/CT followed by excisional biopsy of LNs. MAIN OUTCOME MEASURES: We used PET/CT to assess LN size and metabolic activity. Enlarged LNs were defined as axillary or inguinal LNs with a short axis 1.5 cm or larger; or cervical LN, with a short axis 1.0 cm or larger. We classified LN pathologic results according to National Cancer Institute (LN1-4) and World Health Organization (WHO 1-3) criteria. We quantified PET activity using standardized uptake value (SUV) and correlated with LN grade.
RESULTS: Based on CT size criteria alone, only 5 patients had enlarged LNs, whereas PET revealed hypermetabolic LNs in all 13 patients. Six patients had LN1-3, and 7 had effacement of LN architecture by lymphoma cells (LN4). Of the 7 patients with LN4 nodes, 4 had SS, and 3 had tumorous MF. Two patients with LN4 nodes had inguinal LNs smaller than 1.5 cm and would have been assigned an N0 classification without the use of integrated PET/CT. Correlation of SUV with LN grade revealed that LN1-3 nodes were associated with a mean SUV of 2.7 (median SUV, 2.2; range, 2.0-4.7) and LN4 nodes were associated with a mean SUV of 5.4 (median SUV, 3.9; range, 2.1-11.8). Patients with large cell transformation had the highest SUVs.
CONCLUSIONS: For staging MF and SS, PET/CT was more sensitive in detecting LN involved by lymphoma compared with CT data alone and thus may provide more accurate staging and prognostic information. The intensity of PET activity correlated with histologic LN grade.

Entities:  

Mesh:

Year:  2006        PMID: 16702495     DOI: 10.1001/archderm.142.5.577

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  15 in total

Review 1.  The current management of mycosis fungoides and Sézary syndrome and the role of radiotherapy: Principles and indications.

Authors:  Ercole Mazzeo; Laura Rubino; Michela Buglione; Paolo Antognoni; Stefano Maria Magrini; Francesco Bertoni; Manuela Parmiggiani; Paola Barbieri; Filippo Bertoni
Journal:  Rep Pract Oncol Radiother       Date:  2013-08-13

2.  [Cutaneous malignant lymphomas. Update on diagnosis and therapy of cutaneous T-cell lymphomas].

Authors:  D Humme; M Möbs; S Pullmann; A Haidar; M Beyer; W Sterry; C Assaf
Journal:  Hautarzt       Date:  2012-05       Impact factor: 0.751

3.  PET in T-Cell Lymphoma.

Authors:  Pier Luigi Zinzani
Journal:  Curr Hematol Malig Rep       Date:  2011-12       Impact factor: 3.952

4.  Subcutaneous panniculitis-like T-cell lymphoma with breast involvement: functional and morphological imaging findings.

Authors:  N Schramm; T Pfluger; M F Reiser; F Berger
Journal:  Br J Radiol       Date:  2010-05       Impact factor: 3.039

5.  Role of PET imaging in peritoneal involvement of subcutaneous panniculitis-like T-cell lymphoma.

Authors:  Darren Yak Leong Chan; Nicholas Francis Grigoropoulos; Amos Zhi En Tay; Wanying Xie
Journal:  J Radiol Case Rep       Date:  2022-06-30

6.  Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer center.

Authors:  Yumeng Zhang; Lucia Seminario-Vidal; Christa Varnadoe; Yuanyuan Lu; Ning Dong; Christopher Salamanca; Shannen Whiddon; Janice Bennett; Rebecca Hargis; Hien Liu; Michael Montejo; Mohammad Hussaini; Carly Harro; Jane Messina; Kaaron Benson; Javier Pinilla-Ibarz; Jose Conejo-Garcia; Lubomir Sokol
Journal:  Leuk Lymphoma       Date:  2021-09-01

7.  FDG-PET/CT for the evaluation of response to therapy of cutaneous T-cell lymphoma to vorinostat (suberoylanilide hydroxamic acid, SAHA) in a phase II trial.

Authors:  Phillip H Kuo; Kacie R Carlson; Inger Christensen; Michael Girardi; Peter W Heald
Journal:  Mol Imaging Biol       Date:  2008-07-30       Impact factor: 3.488

8.  FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma.

Authors:  Phillip H Kuo; Bruce L McClennan; Kacie Carlson; Lynn D Wilson; Richard L Edelson; Peter W Heald; Michael Girardi
Journal:  Mol Imaging Biol       Date:  2008-01-15       Impact factor: 3.488

9.  Usefulness of F-18 FDG PET/CT in subcutaneous panniculitis-like T cell lymphoma: disease extent and treatment response evaluation.

Authors:  Jin-Suk Kim; Young Jin Jeong; Myung-Hee Sohn; Hwan-Jeong Jeong; Seok Tae Lim; Dong Wook Kim; Jae-Yong Kwak; Chang-Yeol Yim
Journal:  Radiol Oncol       Date:  2012-11-09       Impact factor: 2.991

10.  Positron emission tomography for staging and response assessment of mycosis fungoides in a child.

Authors:  Indranil Ghosh; M Ramam; Somesh Gupta; Manoj K Singh; Pramod K Julka; Punit Sharma; Sameer Bakhshi
Journal:  Indian J Dermatol       Date:  2013-03       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.